Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Qiagen ( (QGEN) ) is now available.
Qiagen N.V., a prominent entity in the biotechnology sector, has been notified by the Netherlands Authority for the Financial Markets (AFM) regarding a significant voting rights announcement. The notification, dated May 14, 2025, involves BlackRock, Inc., which holds a substantial indirect capital interest and voting rights in Qiagen. This development underscores BlackRock’s significant influence within Qiagen, potentially impacting the company’s strategic decisions and stakeholder interests.
The most recent analyst rating on (QGEN) stock is a Hold with a $42.50 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.
More about Qiagen
Average Trading Volume: 1,333,605
Technical Sentiment Signal: Sell
Current Market Cap: $9.28B
Find detailed analytics on QGEN stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue